If so, then they must know that the results are going to be quite spectacular and market moving.

$HEPA from Twitter Madrigal Conference ▶️ $MDGL Per Management For potential Ex-USA partnership-Significant amount of interest and that interest has heightened significantly especially after Ph3 results per CEO!

Remarkable results i would say….

Yes very very interesting results.

The 28 day data also documented Rencofilstat’s amazingly fast & potent efficacy at reduction of fibrosis that in just 4 short weeks exceeded that of Madrigal’s 12 month hospitalization IV dosage results for their drug used in NASH.

I didnt sell a share and with stellar results for this soon to be released study it should gain traction well over 3 imo.

Brilliant move or some stellar early results.

• Treatment with RCF for 28 days results in a reduction in ceramides, free fatty acids, and triglycerides suggestive of a therapeutic benefit.

We knows recession is coming next year 4) XBI has bottomed and should begin its upward move next year 5) Phase 2b trial results and updates on HCC trial 6) Probable approvals of NASH drugs and increased bullish sentiment in the sector

button for good trial results in the NASH space.

$BXRX The results from interim analysis are so good and think about the future huge market, its exciting

Phase 3 results were solid.

Looking forward to get the next batch of results.

JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results.

It’s up 20% today and still at $0.60 pps Phase 3 pipeline results in a few weeks

$JSPR why baseless rumors .. it deserves high price and good results .. lots of future

top line results anytime here!!

As a result, in a few years, the stock’s value could easily jump 20, 30, or even 50 times over several years." watch $jspr $lhdx $hzn $rsls